The difference between the anti-CPP antibodies sensitivity according to our study and the data in literature seemed to be accounted for by the absence of anti-CCP in RA, possibly because the disease was inactive both clinically and biologically in some of the patients. The gene discussed is CPP; the disease is rheumatoid arthritis.